Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections
Condition(s):Acinetobacter InfectionsLast Updated:September 20, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Acinetobacter InfectionsLast Updated:September 20, 2017Completed
Condition(s):Risk FactorsLast Updated:November 18, 2023Active, not recruiting
Condition(s):HealthyLast Updated:November 9, 2017Completed
Condition(s):Infection During HemodialysisLast Updated:May 31, 2017Completed
Condition(s):Surgical Site InfectionsLast Updated:June 7, 2010Completed
Condition(s):Urinary Tract Infection Complicated; Acute PyelonephritisLast Updated:August 29, 2019Completed
Condition(s):Respiratory Tract Infections; Urinary Tract InfectionsLast Updated:July 8, 2019Completed
Condition(s):Intra-abdominal InfectionLast Updated:August 2, 2011Completed
Condition(s):Respiratory Tract Infections; Urinary Tract InfectionsLast Updated:July 5, 2019Suspended
Condition(s):Carbapenem Resistant Bacterial Infection; Acinetobacter Bacteremia; Acinetobacter PneumoniaLast Updated:February 23, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.